Publications by authors named "Vito Lepore"

Claim this Profile
S
Sex and Gender Transition of People With Multiple Sclerosis: A Real-World Perspective.
Pasquale Paletta, Paola Mosconi, Roberto Bergamaschi, Claudia Santucci, Vito Lepore

Eur J Neurol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Real-World Outcomes Do Not Meet the Results of Clinical Trials: Transfemoral Transcatheter vs. Surgical Aortic Valve Replacement in an Intermediate-Age Population (The Outstanding Italy Study).
Marco Ranucci, Lidia Staszewsky, Massimo Cartabia, Mauro Tettamanti, Vito Lepore

J Clin Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of case-identification algorithms for heart failure in the general population using routinely collected health data: a systematic review.
Anita Andreano, Vito Lepore, Pietro Magnoni, Alberto Milanese, Caterina Fanizza

Syst Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, Ilaria Addazio, Luisa Pastò, Vito Lepore

J Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Registers as central real world data source: the experience of the Italian Multiple Sclerosis and Related Disorders Register].
Michela Ponzio, Mario Alberto Battaglia, Maria Trojano, Marco Salivetto, Antonio D'Ettorre, Vito Lepore

Epidemiol Prev· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
Emilio Portaccio, Matteo Betti, Ermelinda De Meo, Ilaria Addazio, Luisa Pastò, Vito Lepore

J Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal and spatial patterns in the prescriptions of disease-modifying therapies for multiple sclerosis. Results from the Italian Multiple Sclerosis and Related Disorders Register.
Vito Lepore, Pasquale Paletta, Cristina Bosetti, Claudia Santucci, Michela Ponzio

Mult Scler Relat Disord· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study.
Clara G Chisari, Umberto Aguglia, Maria Pia Amato, Roberto Bergamaschi, Antonio Bertolotto, Vito Lepore

Neurotherapeutics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis Progression and Relapse Activity in Children.
Pietro Iaffaldano, Emilio Portaccio, Giuseppe Lucisano, Marta Simone, Alessia Manni, Vito Lepore

JAMA Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Paola Mosconi, Tommaso Guerra, Pasquale Paletta, Antonio D'Ettorre, Michela Ponzio, Vito Lepore

Neurol Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Roberto Bergamaschi, Ettore Beghi, Cristina Bosetti, Michela Ponzio, Claudia Santucci, Vito Lepore

Neurol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression is independent of relapse activity in early multiple sclerosis: a real-life cohort study.
Emilio Portaccio, Angelo Bellinvia, Mattia Fonderico, Luisa Pastò, Lorenzo Razzolini, Vito Lepore

Brain· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.
Pietro Iaffaldano, Giuseppe Lucisano, Alessia Manni, Damiano Paolicelli, Francesco Patti, Vito Lepore

Neurol Neuroimmunol Neuroinflamm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin treatment in patients with diabetes mellitus and heart failure in the era of new antidiabetic medications.
Lidia Staszewsky, Marta Baviera, Mauro Tettamanti, Pierluca Colacioppo, Fabio Robusto, Vito Lepore

BMJ Open Diabetes Res Care· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort.
Edoardo Bertero, Fabio Robusto, Eliana Rulli, Antonio D'Ettorre, Lucia Bisceglia, Vito Lepore

JACC CardioOncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study.
Clara G Chisari, Giancarlo Comi, Massimo Filippi, Damiano Paolicelli, Pietro Iaffaldano, Vito Lepore

J Neurol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratification of the risk of developing severe or lethal Covid-19 using a new score from a large Italian population: a population-based cohort study.
Giovanni Corrao, Federico Rea, Flavia Carle, Salvatore Scondotto, Alessandra Allotta, Vito Lepore

BMJ Open· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower risk of death and cardiovascular events in patients with diabetes initiating glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors: A real-world study in two Italian cohorts.
Marta Baviera, Stefano Genovese, Vito Lepore, Pierluca Colacioppo, Fabio Robusto

Diabetes Obes Metab· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis.
Clara Grazia Chisari, Luigi Maria Grimaldi, Giuseppe Salemi, Paolo Ragonese, Pietro Iaffaldano, Vito Lepore

J Neurol Neurosurg Psychiatry· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring multimorbidity inequality across Italy through the multisource comorbidity score: a nationwide study.
Giovanni Corrao, Federico Rea, Flavia Carle, Mirko Di Martino, Rossana De Palma, Vito Lepore

Eur J Public Health· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular mortality and morbidity burden in successive and age pre-stratified case-control cohorts of breast cancer women. A population-based study.
Lidia Staszewsky, Fabio Robusto, Vito Lepore, Lucia Bisceglia, Vito Petrarolo

Breast Cancer Res Treat· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Italian multiple sclerosis register.
Maria Trojano, Roberto Bergamaschi, Maria Pia Amato, Giancarlo Comi, Angelo Ghezzi, Vito Lepore

Neurol Sci· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Italian multiple sclerosis register.
Maria Trojano, Roberto Bergamaschi, Maria Pia Amato, Giancarlo Comi, Angelo Ghezzi, Vito Lepore

Neurol Sci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Franco Cosmi, Li Shen, Michela Magnoli, William T Abraham, Inder S Anand, Vito Lepore

Eur J Heart Fail· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of the introduction of a chronic care model-based program on utilization of healthcare resources: the results of the Puglia care program.
Fabio Robusto, Lucia Bisceglia, Vito Petrarolo, Francesca Avolio, Elisabetta Graps, Vito Lepore

BMC Health Serv Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis